Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype

Manu Banadakoppa1, Meena Balakrishnan2, Chandra Yallampalli3

  • 1Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, Texas, USA. banadako@bcm.edu.

Scientific Reports
|March 18, 2020
PubMed

Insights

Preeclampsia (PE) risk may be linked to specific genetic variations in maternal and fetal complement genes, forming unique "complotypes." These genetic combinations appear more common in women with PE, suggesting a predisposition.

Area of Science:

  • Immunogenetics
  • Reproductive Medicine
  • Perinatal Health

Background:

  • Preeclampsia (PE) is a pregnancy-specific hypertensive disorder with potential life-threatening complications like eclampsia.
  • Elevated systemic complement activation and placental deposition are observed in PE pregnancies.
  • The role of genetic variations in complement pathways predisposing to PE requires further investigation.

Purpose of the Study:

  • To investigate the hypothesis that combinations of common single nucleotide polymorphisms (SNPs) in maternal and fetal complement genes form pregnancy-specific complotypes that predispose women to PE.
  • To identify common SNPs in maternal (factor H, C3) and fetal (CD46) complement genes and analyze their association with PE.
  • To examine the relationship between identified genetic variants, placental complement deposition, and maternal alternative pathway activity.

Main Methods:

  • Sequencing of maternal factor H (CFH) and C3 genes, and fetal CD46 gene to identify common SNPs.
  • Genotyping analysis to determine the prevalence of identified SNPs and complotypes in PE patients and normotensive controls.
  • Measurement of placental complement deposition and maternal alternative pathway 50 (AP50) activity.
  • Assessment of placental CD46 expression and association with specific CD46 variants.

Main Results:

  • Nine common SNPs were identified in the studied complement genes.
  • Two fetal CD46 SNPs showed significantly higher minor allele frequencies in PE patients.
  • Complotypes combining fetal CD46 variants with maternal CFH/C3 variants were more prevalent in PE pregnancies.
  • Higher placental complement deposition and maternal AP50 values were observed in PE pregnancies.
  • Specific CD46 variants correlated with reduced placental CD46 expression, and a CFH variant with increased maternal AP50.

Conclusions:

  • Specific combinations of maternal and fetal complement gene variants (complotypes) are associated with an increased prevalence in preeclampsia.
  • Fetal CD46 and maternal CFH/C3 gene variants may play a role in PE susceptibility.
  • Genetic variations in complement genes influence placental complement deposition and maternal alternative pathway activity, contributing to PE pathophysiology.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
8.9K
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
5.9K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.0K